An fMRI Study Of Brain Response In Patients With Fibromyalgia

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to explore how pregabalin works in patients with fibromyalgia by evaluating brain imaging signals. To find out whether fMRI (functional magnetic resonance imaging) is an efficient way to show whether new pain medications are effective in treating fibromyalgia.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Women must have pain due to fibromyalgia

• Fibromyalgia must have been diagnosed at least 6 months prior to be eligible for this study

Exclusion Criteria:

• Patients with severe depression or other serious illness, who are left-handed, or who are pregnant or nursing are not eligible for this study.